| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |